US Stock MarketDetailed Quotes

APDN Applied DNA Sciences

Watchlist

1.760
-0.110-5.88%

Close Mar 28 16:00 ET

1.731
-0.029-1.67%

Post 20:01 ET

1.94MMarket Cap-0.05P/E (TTM)

Applied DNA Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Applied DNA Sciences Q1 2025 Earnings Date

Currency：USDFeb 13, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	1.18M	1.20M	+21.62K
Beat Est.	+31.85%	+34.28%	+1.84%
EPS	-16.50	-28.00	-11.50
Miss Est.	+81.67%	+67.63%	-69.70%

Analyst Rating

Hold

Feb 27, 2025

Applied DNA Sciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q3	-- / 1.276M	--
--	2025/Q2	-- / 1.185M	--
Feb 13, 2025	2025/Q1	1.197M / 1.175M	--
Dec 17, 2024	2024/Q4	813.110K / 899.000K	--
Aug 8, 2024	2024/Q3	797.520K / 1.079M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q3-- / 1.276M--

--2025/Q2-- / 1.185M--

Feb 13, 20252025/Q11.197M / 1.175M--

Dec 17, 20242024/Q4813.110K / 899.000K--

Aug 8, 20242024/Q3797.520K / 1.079M--

Unlock Free Earnings Estimates

Open Account

Applied DNA Sciences Earnings Reports

10-Q: Q1 2025 Earnings Report

Feb 13 16:15 ET

8-K: Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress - Announces Exit of DNA Tagging and Security Products and Services Business Segment -

Feb 13 16:10 ET

10-K: FY2024 Annual Report

Dec 17, 2024 16:44 ET

8-K: Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Dec 17, 2024 16:14 ET

Market Insights